CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

KRAS G12C

Gene: KRAS · Type: mutation

Indications: Non-small cell lung cancer

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
SotorasibNon-small cell lung cancerINDICATED
FDA Label
Label
AdagrasibNon-small cell lung cancerINDICATED
FDA Label
Label